MDxHealth (MDXH) Net Income towards Common Stockholders (2021 - 2026)
MDxHealth (MDXH) posted Net Income towards Common Stockholders of $8.9 million for Q1 2026, up 199.32% sequentially from -$8.9 million in Q4 2025, and down 3.71% YoY from $9.2 million in Q1 2025.
MDxHealth (MDXH) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
MDxHealth has reported Net Income towards Common Stockholders for 6 years, with the latest figure at $8.9 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 3.71% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$24.7 million (down 21.5% YoY) and the FY2025 annual result came in at -$33.5 million, up 11.95% from the prior year.
- Net Income towards Common Stockholders improved to $8.9 million in Q1 2026 per MDXH's latest filing, from -$8.9 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $18.1 billion in Q2 2022 and troughed at -$24.6 million in Q3 2025.
- A 5-year average of $1.1 billion and a median of -$8.3 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders surged 253.9% in 2022, then plunged 163.82% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at $12.4 million in 2022, then dropped by 13.81% to $10.7 million in 2023, then plunged by 163.82% to -$6.8 million in 2024, then slumped by 30.51% to -$8.9 million in 2025, then jumped by 199.32% to $8.9 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $8.9 million, -$8.9 million, and -$24.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | MDxHealth | 21.81 Mn | -21.34 Mn | 16.61 Mn | -8.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.87 Mn |
| Dec 31, 2025 | -8.93 Mn |
| Sep 30, 2025 | -24.59 Mn |
| Jun 30, 2025 | -71,766.00 |
| Mar 31, 2025 | 9.21 Mn |
| Dec 31, 2024 | -6.84 Mn |
| Sep 30, 2024 | -11.19 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | 8.51 Mn |
| Dec 31, 2023 | 10.72 Mn |
| Sep 30, 2023 | -10.05 Mn |
| Jun 30, 2023 | -10.63 Mn |
| Mar 31, 2023 | -11.71 Mn |
| Dec 31, 2022 | 12.44 Mn |
| Sep 30, 2022 | -13.50 Mn |
| Jun 30, 2022 | 18.11 Bn |
| Mar 31, 2022 | -8.27 Mn |
| Dec 31, 2021 | -8.08 Mn |
| Sep 30, 2021 | -7.62 Mn |